vs

Side-by-side financial comparison of Tilray Brands, Inc. (TLRY) and Victory Capital Holdings, Inc. (VCTR). Click either name above to swap in a different company.

Victory Capital Holdings, Inc. is the larger business by last-quarter revenue ($374.1M vs $217.5M, roughly 1.7× Tilray Brands, Inc.). Victory Capital Holdings, Inc. runs the higher net margin — 30.2% vs -20.7%, a 50.8% gap on every dollar of revenue. On growth, Victory Capital Holdings, Inc. posted the faster year-over-year revenue change (61.0% vs 3.1%). Over the past eight quarters, Victory Capital Holdings, Inc.'s revenue compounded faster (31.7% CAGR vs 7.5%).

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

Victory Capital Holdings, Inc. is an American financial services company headquartered in San Antonio, Texas that focuses on investment management. Outside the US, it also has investment professionals in London, Hong Kong and Singapore.

TLRY vs VCTR — Head-to-Head

Bigger by revenue
VCTR
VCTR
1.7× larger
VCTR
$374.1M
$217.5M
TLRY
Growing faster (revenue YoY)
VCTR
VCTR
+57.9% gap
VCTR
61.0%
3.1%
TLRY
Higher net margin
VCTR
VCTR
50.8% more per $
VCTR
30.2%
-20.7%
TLRY
Faster 2-yr revenue CAGR
VCTR
VCTR
Annualised
VCTR
31.7%
7.5%
TLRY

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
TLRY
TLRY
VCTR
VCTR
Revenue
$217.5M
$374.1M
Net Profit
$-44.9M
$112.8M
Gross Margin
26.4%
Operating Margin
-10.2%
40.9%
Net Margin
-20.7%
30.2%
Revenue YoY
3.1%
61.0%
Net Profit YoY
47.4%
46.6%
EPS (diluted)
$-0.41
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TLRY
TLRY
VCTR
VCTR
Q4 25
$217.5M
$374.1M
Q3 25
$209.5M
$361.2M
Q2 25
$224.5M
$351.2M
Q1 25
$185.8M
$219.6M
Q4 24
$210.9M
$232.4M
Q3 24
$200.0M
$225.6M
Q2 24
$229.9M
$219.6M
Q1 24
$188.3M
$215.9M
Net Profit
TLRY
TLRY
VCTR
VCTR
Q4 25
$-44.9M
$112.8M
Q3 25
$-322.0K
$96.5M
Q2 25
$-1.3B
$58.7M
Q1 25
$-789.4M
$62.0M
Q4 24
$-85.3M
$76.9M
Q3 24
$-39.2M
$82.0M
Q2 24
$-31.7M
$74.3M
Q1 24
$-92.7M
$55.7M
Gross Margin
TLRY
TLRY
VCTR
VCTR
Q4 25
26.4%
Q3 25
27.4%
Q2 25
30.1%
Q1 25
28.0%
Q4 24
29.0%
Q3 24
29.8%
Q2 24
35.8%
Q1 24
26.2%
Operating Margin
TLRY
TLRY
VCTR
VCTR
Q4 25
-10.2%
40.9%
Q3 25
1.0%
38.2%
Q2 25
-643.1%
26.8%
Q1 25
-409.0%
42.3%
Q4 24
-20.0%
48.1%
Q3 24
-18.3%
53.3%
Q2 24
-7.2%
50.4%
Q1 24
-43.6%
39.3%
Net Margin
TLRY
TLRY
VCTR
VCTR
Q4 25
-20.7%
30.2%
Q3 25
-0.2%
26.7%
Q2 25
-566.9%
16.7%
Q1 25
-424.9%
28.2%
Q4 24
-40.5%
33.1%
Q3 24
-19.6%
36.3%
Q2 24
-13.8%
33.8%
Q1 24
-49.2%
25.8%
EPS (diluted)
TLRY
TLRY
VCTR
VCTR
Q4 25
$-0.41
$1.33
Q3 25
$0.00
$1.11
Q2 25
$7.26
$0.68
Q1 25
$-8.69
$0.96
Q4 24
$-0.99
$1.18
Q3 24
$-0.04
$1.24
Q2 24
$-0.04
$1.12
Q1 24
$-0.12
$0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TLRY
TLRY
VCTR
VCTR
Cash + ST InvestmentsLiquidity on hand
$291.6M
$163.7M
Total DebtLower is stronger
$970.0M
Stockholders' EquityBook value
$1.6B
$2.4B
Total Assets
$2.1B
$4.2B
Debt / EquityLower = less leverage
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TLRY
TLRY
VCTR
VCTR
Q4 25
$291.6M
$163.7M
Q3 25
$264.8M
$115.7M
Q2 25
$256.4M
$107.9M
Q1 25
$175.6M
Q4 24
$252.2M
$126.7M
Q3 24
$280.1M
$188.2M
Q2 24
$260.5M
$119.0M
Q1 24
$225.9M
$79.9M
Total Debt
TLRY
TLRY
VCTR
VCTR
Q4 25
$970.0M
Q3 25
$972.0M
Q2 25
$965.7M
Q1 25
$964.8M
Q4 24
$963.9M
Q3 24
$982.7M
Q2 24
$981.7M
Q1 24
$990.2M
Stockholders' Equity
TLRY
TLRY
VCTR
VCTR
Q4 25
$1.6B
$2.4B
Q3 25
$1.5B
$2.4B
Q2 25
$1.5B
$2.5B
Q1 25
$2.7B
$1.1B
Q4 24
$3.5B
$1.1B
Q3 24
$3.5B
$1.2B
Q2 24
$3.4B
$1.1B
Q1 24
$3.4B
$1.1B
Total Assets
TLRY
TLRY
VCTR
VCTR
Q4 25
$2.1B
$4.2B
Q3 25
$2.1B
$4.2B
Q2 25
$2.1B
$4.2B
Q1 25
$2.6B
Q4 24
$4.2B
$2.5B
Q3 24
$4.3B
$2.6B
Q2 24
$4.2B
$2.5B
Q1 24
$4.2B
$2.5B
Debt / Equity
TLRY
TLRY
VCTR
VCTR
Q4 25
0.40×
Q3 25
0.41×
Q2 25
0.39×
Q1 25
0.84×
Q4 24
0.86×
Q3 24
0.84×
Q2 24
0.87×
Q1 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TLRY
TLRY
VCTR
VCTR
Operating Cash FlowLast quarter
$-8.5M
$145.1M
Free Cash FlowOCF − Capex
$144.5M
FCF MarginFCF / Revenue
38.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.29×
TTM Free Cash FlowTrailing 4 quarters
$381.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TLRY
TLRY
VCTR
VCTR
Q4 25
$-8.5M
$145.1M
Q3 25
$-1.3M
$165.9M
Q2 25
$-12.8M
$-6.6M
Q1 25
$-5.8M
$81.1M
Q4 24
$-40.7M
$91.8M
Q3 24
$-35.3M
$99.8M
Q2 24
$30.7M
$79.7M
Q1 24
$-15.4M
$68.7M
Free Cash Flow
TLRY
TLRY
VCTR
VCTR
Q4 25
$144.5M
Q3 25
$164.8M
Q2 25
$-19.1M
$-7.5M
Q1 25
$-20.2M
$79.5M
Q4 24
$-46.2M
$91.7M
Q3 24
$-42.0M
$99.4M
Q2 24
$21.0M
$79.5M
Q1 24
$-24.9M
$68.2M
FCF Margin
TLRY
TLRY
VCTR
VCTR
Q4 25
38.6%
Q3 25
45.6%
Q2 25
-8.5%
-2.1%
Q1 25
-10.9%
36.2%
Q4 24
-21.9%
39.4%
Q3 24
-21.0%
44.0%
Q2 24
9.1%
36.2%
Q1 24
-13.2%
31.6%
Capex Intensity
TLRY
TLRY
VCTR
VCTR
Q4 25
0.2%
Q3 25
0.3%
Q2 25
2.8%
0.3%
Q1 25
7.8%
0.7%
Q4 24
2.6%
0.1%
Q3 24
3.4%
0.2%
Q2 24
4.2%
0.1%
Q1 24
5.1%
0.2%
Cash Conversion
TLRY
TLRY
VCTR
VCTR
Q4 25
1.29×
Q3 25
1.72×
Q2 25
-0.11×
Q1 25
1.31×
Q4 24
1.19×
Q3 24
1.22×
Q2 24
1.07×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

VCTR
VCTR

Investment Management Fees$301.4M81%
Fund Administration And Distribution Fees$72.8M19%

Related Comparisons